Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
142.69B
Market cap142.69B
Price-Earnings ratio
19.18
Price-Earnings ratio19.18
Dividend yield
6.88%
Dividend yield6.88%
Average volume
36.95M
Average volume36.95M
High today
$25.28
High today$25.28
Low today
$24.70
Low today$24.70
Open price
$25.02
Open price$25.02
Volume
8.88M
Volume8.88M
52 Week high
$28.75
52 Week high$28.75
52 Week low
$23.40
52 Week low$23.40

Stock Snapshot

The current Pfizer(PFE) stock price is $24.96, with a market capitalization of 142.69B. The stock trades at a price-to-earnings (P/E) ratio of 19.18 and offers a dividend yield of 6.88%.

On 2026-08-04, Pfizer(PFE) stock traded between a low of $24.70 and a high of $25.28. Shares are currently priced at $24.96, which is +1.1% above the low and -1.3% below the high.

The Pfizer(PFE)'s current trading volume is 8.88M, compared to an average daily volume of 36.95M.

During the past year, Pfizer(PFE) stock moved between $23.40 at its lowest and $28.75 at its peak.

During the past year, Pfizer(PFE) stock moved between $23.40 at its lowest and $28.75 at its peak.

PFE News

Benzinga 30m
Dow Jumps Over 700 Points; Pfizer Posts Upbeat Q2 Earnings

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 700 points on Tuesday. Following the market opening Tuesday, the Dow traded u...

Dow Jumps Over 700 Points; Pfizer Posts Upbeat Q2 Earnings
Nasdaq 1h
Pfizer Q2 26 Earnings Conference Call At 10:00 AM ET

(RTTNews) - Pfizer Inc. (PFE) will host a conference call at 10:00 AM ET on August 4, 2026, to discuss Q2 26 earnings results. To access the live webcast, log...

Pfizer Q2 26 Earnings Conference Call At 10:00 AM ET
Simply Wall St 2h
Is Pfizer A Bargain Following Its Earnings Beat And 2026 Guidance Lift?

Pfizer (PFE) is back in focus after reporting a second quarter earnings beat, raising its 2026 revenue guidance midpoint by US$500 million, and highlighting new...

Is Pfizer A Bargain Following Its Earnings Beat And 2026 Guidance Lift?

Analyst ratings

62%

of 29 ratings
Buy
31%
Hold
62.1%
Sell
6.9%

More PFE News

Seeking Alpha 3h
Pfizer tops Q2 expectations, boosts revenue guidance

Pfizer (NYSE: PFE) reported second-quarter results that topped Wall Street expectations and raised its full-year revenue outlook, driven by stronger-than-expect...

Pfizer tops Q2 expectations, boosts revenue guidance
The Wall Street Journal 3h
Pfizer Post Loss on Higher Revenue

Pfizer swung to a second-quarter loss. angela weiss / Agence France-Presse / Getty Images Pfizer PFE 0.08 %increase; up pointing triangle swung to a second-qua...

Pfizer Post Loss on Higher Revenue
CNBC 3h
Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Pfizer Inc. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Wednesday, March 4, 2026. Pfizer on Tuesday reported second-quarter...

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products
TipRanks 3h
Pfizer reports Q2 adjusted EPS 77c, consensus 68c

Reports Q2 revenue $15B, consensus $14.39B. “Pfizer (PFE) had another strong quarter, delivering on our financial commitments and advancing our strategy. Our la...

Benzinga 8h
Pfizer Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Pfizer Inc. (NYSE:PFE) will release its second quarter earnings report before the opening bell on Tuesday, Aug. 4. Analysts expect the New York-based company t...

Pfizer Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Nasdaq 19h
Pfizer's Stock Has Been a Dud Over the Past 5 Years, but Is It Still Worth Buying for Its 6.9% Yield?

Key Points Pfizer has consistently been paying its shareholders a dividend for decades. The company has also carefully raised its dividend, ensuring the payou...

Pfizer's Stock Has Been a Dud Over the Past 5 Years, but Is It Still Worth Buying for Its 6.9% Yield?
Seeking Alpha 22h
Pfizer, Merck Q2 preview: New growth bets face legacy headwinds

Healthcare giants Pfizer (PFE) and Merck (MRK) are scheduled to report their quarterly earnings on Tuesday, with analysts expecting a decline in their bottom li...

Pfizer, Merck Q2 preview: New growth bets face legacy headwinds

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.